These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 22505997)

  • 21. Mechanism of human PTEN localization revealed by heterologous expression in Dictyostelium.
    Nguyen HN; Afkari Y; Senoo H; Sesaki H; Devreotes PN; Iijima M
    Oncogene; 2014 Dec; 33(50):5688-96. PubMed ID: 24292679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Engineering PTEN function: membrane association and activity.
    Yang JM; Nguyen HN; Sesaki H; Devreotes PN; Iijima M
    Methods; 2015 May; 77-78():119-24. PubMed ID: 25448479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of Human PTEN-L in a Yeast Heterologous Model Unveils Specific N-Terminal Motifs Controlling PTEN-L Subcellular Localization and Function.
    Fernández-Acero T; Bertalmio E; Luna S; Mingo J; Bravo-Plaza I; Rodríguez-Escudero I; Molina M; Pulido R; Cid VJ
    Cells; 2019 Nov; 8(12):. PubMed ID: 31779149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PTEN inhibits BMI1 function independently of its phosphatase activity.
    Fan C; He L; Kapoor A; Rybak AP; De Melo J; Cutz JC; Tang D
    Mol Cancer; 2009 Nov; 8():98. PubMed ID: 19903340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of surface plasmon resonance for studies of protein-protein and protein-phospholipid membrane interactions. Application to the binding of factor VIII to von Willebrand factor and to phosphatidylserine-containing membranes.
    Saenko E; Sarafanov A; Greco N; Shima M; Loster K; Schwinn H; Josic D
    J Chromatogr A; 1999 Aug; 852(1):59-71. PubMed ID: 10480230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biophysical methods for the characterization of PTEN/lipid bilayer interactions.
    Harishchandra RK; Neumann BM; Gericke A; Ross AH
    Methods; 2015 May; 77-78():125-35. PubMed ID: 25697761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fine-Tuning of Pten Localization and Phosphatase Activity Is Essential for Zebrafish Angiogenesis.
    Stumpf M; Blokzijl-Franke S; den Hertog J
    PLoS One; 2016; 11(5):e0154771. PubMed ID: 27138341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The PTEN Tumor Suppressor Forms Homodimers in Solution.
    Heinrich F; Chakravarthy S; Nanda H; Papa A; Pandolfi PP; Ross AH; Harishchandra RK; Gericke A; Lösche M
    Structure; 2015 Oct; 23(10):1952-1957. PubMed ID: 26299948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor suppressor PTEN acts through dynamic interaction with the plasma membrane.
    Vazquez F; Matsuoka S; Sellers WR; Yanagida T; Ueda M; Devreotes PN
    Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3633-8. PubMed ID: 16537447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PTEN hopping on the cell membrane is regulated via a positively-charged C2 domain.
    Yasui M; Matsuoka S; Ueda M
    PLoS Comput Biol; 2014 Sep; 10(9):e1003817. PubMed ID: 25211206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein Chemical Approaches to Understanding PTEN Lipid Phosphatase Regulation.
    Dempsey DR; Cole PA
    Methods Enzymol; 2018; 607():405-422. PubMed ID: 30149868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors.
    Freeburn RW; Wright KL; Burgess SJ; Astoul E; Cantrell DA; Ward SG
    J Immunol; 2002 Nov; 169(10):5441-50. PubMed ID: 12421919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor suppressor PTEN mediates sensing of chemoattractant gradients.
    Iijima M; Devreotes P
    Cell; 2002 May; 109(5):599-610. PubMed ID: 12062103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular Features of Phosphatase and Tensin Homolog (PTEN) Regulation by C-terminal Phosphorylation.
    Chen Z; Dempsey DR; Thomas SN; Hayward D; Bolduc DM; Cole PA
    J Biol Chem; 2016 Jul; 291(27):14160-14169. PubMed ID: 27226612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PDZ domains of Par-3 as potential phosphoinositide signaling integrators.
    Wu H; Feng W; Chen J; Chan LN; Huang S; Zhang M
    Mol Cell; 2007 Dec; 28(5):886-98. PubMed ID: 18082612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phospholipid composition dependence of Ca2+-dependent phospholipid binding to the C2A domain of synaptotagmin IV.
    Fukuda M; Kojima T; Mikoshiba K
    J Biol Chem; 1996 Apr; 271(14):8430-4. PubMed ID: 8626542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamics and structural stability effects of germline PTEN mutations associated with cancer versus autism phenotypes.
    Smith IN; Thacker S; Jaini R; Eng C
    J Biomol Struct Dyn; 2019 Apr; 37(7):1766-1782. PubMed ID: 29663862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Axonal Membrane Protein PRG2 Inhibits PTEN and Directs Growth to Branches.
    Brosig A; Fuchs J; Ipek F; Kroon C; Schrötter S; Vadhvani M; Polyzou A; Ledderose J; van Diepen M; Holzhütter HG; Trimbuch T; Gimber N; Schmoranzer J; Lieberam I; Rosenmund C; Spahn C; Scheerer P; Szczepek M; Leondaritis G; Eickholt BJ
    Cell Rep; 2019 Nov; 29(7):2028-2040.e8. PubMed ID: 31722215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A short N-terminal sequence of PTEN controls cytoplasmic localization and is required for suppression of cell growth.
    Denning G; Jean-Joseph B; Prince C; Durden DL; Vogt PK
    Oncogene; 2007 Jun; 26(27):3930-40. PubMed ID: 17213812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Membrane binding mechanisms of the PX domains of NADPH oxidase p40phox and p47phox.
    Stahelin RV; Burian A; Bruzik KS; Murray D; Cho W
    J Biol Chem; 2003 Apr; 278(16):14469-79. PubMed ID: 12556460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.